Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Dominik Ruettinger
Person

Dominik Ruettinger

Tracked across 1 events · 7 articles · First seen Feb 27, 2026 · Last active Feb 27, 2026

Sentiment
50
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 50
Tech
Bayer's Ac-PSMA-Trillium Phase I Success
Dominik Ruettinger, Head of Research and Early Development for Oncology at Bayer's Pharmaceuticals Division, expressed excitement about the Phase I PAnTHa study results, highlighting Bayer's continued focus on prostate cancer treatment and personalized healthcare solutions.
Feb 27, 2026 · 7 articles
NEWSDESK
Track Dominik Ruettinger live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.